Kathleen Berst

Deputy Commander of Acquisition and the Acting Director of the Clinical Services Support Division

U.S. Army Medical Materiel Development Activity (USAMMDA)

Mrs. Kathleen Berst is the Deputy Commander of Acquisition and the Acting Director of the Clinical Services Support Division at the United States Army Medical Materiel Development Activity, responsible for oversight of five Project Management Offices and all aspects of clinical and regulatory support for a large portfolio of drugs, vaccines and devices.

Berst graduated from Clarkson University in Potsdam, New York in 1997 with a Bachelor of Science Degree in Molecular Biology. She is taking her final courses for a Masters of Business Administration from Hood College in Frederick, Maryland. Berst is a member of the Army Acquisition Corps and holds Defense Acquisition Workforce Improvement Act Level III certification in Program Management. Additionally, Berst has achieved Program Management Professional certification and a Regulatory Affairs Certification.

Berst has held numerous progressive positions within the DoD medical community. She served as a Biologist as the U.S. Army Medical Research Institute for Infectious Diseases, conducting research on medical countermeasures against Yersinia pestis, the causative agent of plague, and Bacillus anthracis, the causative agent of anthrax. In 2001, she left the laboratory and started working for the Joint Vaccine Acquisition Program. In her ten years at JVAP in biodefense vaccine development, she advanced from Assistant Vaccine Manager to Director of Development Program Integration. In that role, Berst was responsible for the oversight of multiple vaccine advanced development programs, advancing products from pre-Investigational New Drug through Phase 2 clinical trials. Prior to her current position at USAMMDA, Berst was the Project Manager for the Medical Countermeasure Test and Evaluation Facility. In that role, she led a team to establish a test and evaluation capability within existing facilities and terminated plans to build a new 460,000 square foot facility that was already funded. This decision saved the DoD over $1 Billion. In 2012, Berst became the acting Director of the Armed Forces Institute of Regenerative Medicine Project Management Office, leading a team responsible for managing a diverse portfolio of research and development efforts for novel products to treat and restore Service Members from traumatic injuries.

Berst's awards include three Department of the Army Commander's Awards for Civilian Service, Federal Executive Career Service Award (Gold) for Outstanding Professional (Non-Supervisory) Technical, Scientific, and Program Support, Department of the Army Superior Civilian Service Award, Fort Detrick Woman of the Year (2011), Department of Army Order of Military Medical Merit, and Department of Defense Distinguished Civilian Service Award.